(Kamath, M.S. et al (2004) Efficacy and safety of ForsLean® in increasing Lean Body Mass.
Department of Ayurvedic Medicine, Kasturba Medical College, Manipal, India)
50 subjects, male and female, were randomized to receive 250 mg of ForsLean® capsules twice a day for 12 weeks. A significant decrease in body weight and fat content and a significant increase in lean body mass were observed (Figure 7).
The mean percentage lean body mass increased by 1.78% in the ForsLean® group, while the placebo group showed a mean decrease of 0.2% of LBM from baseline values. The mean percentage body fat content in the ForsLean® group was 34% as compared to 39% in placebo receiving group at the end of the 12-week trial.
Sabinsa Wins Again: Federal Court Denies Creative Compounds Motion
Listen to a brief video on ForsLean®
View past and recent advertisements
Innovative Ingredients Paper Weight loss approach
Sabinsa calls to readers' attention that some of the products, protocols and uses of the products described here in are or may be subject to various restrictions or limitations because of patents, exclusive or nonexclusive licenses, confidentiality agreements and other intellectual property or equivalent rights. Readers are advised to make an early and thorough investigation and inquiry into any product, protocol or use in which they may be interested, to see if any such rights might be applicable. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.